Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.76

-2.1%

Dec 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2979)	7/26/2010 12:26:31 PM
From: Jibacoa	Read Replies (1) of 3722

OREX is trying to rally after its recent setback.<g> The stock was up 10.34% and is still up 5.98% on volume >3/4 its ADV bigcharts.marketwatch.com The stock was hurt on July 15 from the FDA's panel decision on VVUS Qnexa, since OREX's Contrave had also reported last Yr. good results on its PIII for the treatment of obesity.<g> The ACTAY has been trimmed to $11.80 The stock has now a good amount of resistance at the $6 level, which is where I will still keep a TT.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next